+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sildenafil is a pulmonary vasodilator which augments and prolongs vasodilatation by inhaled nitric oxide in patients with pulmonary hypertension



Sildenafil is a pulmonary vasodilator which augments and prolongs vasodilatation by inhaled nitric oxide in patients with pulmonary hypertension



Circulation 100(18 Suppl. ): I 240




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035730600

Download citation: RISBibTeXText


Related references

Phosphodiesterase inhibition with dipyridamole augments and prolongs the pulmonary vasodilator response to inhaled nitric oxide in adults with chronic pulmonary hypertension. Circulation 98(17 Suppl. ): I614, 1998

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 105(20): 2398-2403, 2002

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. American Journal of Cardiology 90(6): 677-680, 2002

Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology 290(4): L723-L729, 2006

Stimulation of soluble guanylate cyclase attenuates acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide. FASEB Journal 18(4-5): Abst 688 14, 2004

Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation 110(15): 2253-2259, 2004

Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clinics in Perinatology 39(1): 149-164, 2012

Inhaled carbon monoxide produces additional pulmonary vasodilatation in the treatment of hypoxic pulmonary hypertension with inhaled nitric oxide in newborn piglets. Pediatric Research 51(4 Part 2): 330A, 2002

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338(8776): 1173-1174, 1991

Inhaled nitric oxide in primary pulmonary hypertension The Perfect pulmonary vasodilator. Circulation 92(8 Suppl. ): I241, 1995

Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. Journal of Thoracic and Cardiovascular Surgery 124(3): 628-629, 2002

Inhaled nitric oxide a selective pulmonary vasodilator for the treatment of persistent pulmonary hypertension of the newborn pphn. Circulation 84(4 Suppl. 2): II321, 1991

Vasodilator response to inhaled nitric oxide is the most powerful predictor of survival in patients with pulmonary hypertension. Circulation 108(17 Suppl.): IV-561, 2003

The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. American Heart Journal 150(4): 725-728, 2005